VAERS reports by lot

GSK Varicella/Shingles lot 54TF4: VAERS reports

24 VAERS reports list lot 54TF4 as a GSK Varicella/Shingles vaccine, received between 2022-02-08 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3249%
General / Systemic (non-local)1117%
Dermatological (non-injection-site)69%
Neurological58%
Musculoskeletal58%
Gastrointestinal35%
Cardiac / Cardiovascular12%
Allergic / Anaphylactic12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 9).

Connecticut6
Texas6
Massachusetts5
New Mexico2
California1
North Carolina1
Colorado1
Rhode Island1
New Hampshire1

Reports by month received

2022-021
2022-032
2022-043
2022-052
2022-066
2022-076
2022-082
2022-091
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.